OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Florian Huber, Marion Arnaud, Brian J. Stevenson, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 7
Florian Huber, Marion Arnaud, Brian J. Stevenson, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 7
Showing 7 citing articles:
The clinical application of artificial intelligence in cancer precision treatment
Jinyu Wang, Ziyi Zeng, Zehua Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Jinyu Wang, Ziyi Zeng, Zehua Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Interdisciplinary Approaches to Leverage Biomarker Discovery for Cancer Treatment
Fatemeh Khatami, Nima Rezaei
Interdisciplinary cancer research (2025)
Closed Access
Fatemeh Khatami, Nima Rezaei
Interdisciplinary cancer research (2025)
Closed Access
Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Spotlight on cancer immunotherapies
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 453-454
Closed Access
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 453-454
Closed Access
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Moawiah M. Naffaa, Ola A Al-Ewaidat, Sopiko Gogia, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
A post-translational cysteine-to-serine conversion in human and mouse insulin generates a diabetogenic neoepitope
Neetu Srivastava, Anthony N. Vomund, Orion J. Peterson, et al.
(2024)
Closed Access | Times Cited: 1
Neetu Srivastava, Anthony N. Vomund, Orion J. Peterson, et al.
(2024)
Closed Access | Times Cited: 1
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S. Heitmann, Susanne Jung, Marcel Wacker, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jonas S. Heitmann, Susanne Jung, Marcel Wacker, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Advances of computational methods enhance the development of multi-epitope vaccines
Yiwen Wei, Tianyi Qiu, Yisi Ai, et al.
Briefings in Bioinformatics (2024) Vol. 26, Iss. 1
Open Access
Yiwen Wei, Tianyi Qiu, Yisi Ai, et al.
Briefings in Bioinformatics (2024) Vol. 26, Iss. 1
Open Access
